BCAX
Bicara Therapeutics Inc.Open17.49+0.16 +0.92%USD
NasdaqGM · as of Oct 13, 14:50 ET · 15m delay
Open
17.29
Prev close
17.33
Day range
17.0117.61
52-week range
13.7030.99
Volume
712.70K1.13×
Mkt cap
1.16B
P/E ttm
—
Fwd P/E
-4.97
EPS ttm
-3.08
Div yield
0.00%
Earnings
Aug 11, 2026
From 52w high
−43.56%
BCAX shareholders
BCAX Ownership
13F / N-PORT filings via Yahoo
Institutions
102.3%
113.7% of the float
Insiders
10.1%
officers and directors
Institutional holders
239
filing positions
Top 10 institutions
66.4%
4 adding · 4 trimming
Top Institutions
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 10.97% | 7.26M | $126.91M | 0.0% | Jun 30, 2026 |
| T. Rowe Price Investment Management, Inc. | 9.58% | 6.34M | $110.86M | −4.0% | Jun 30, 2026 |
| Siren, L.L.C. | 8.47% | 5.60M | $98.00M | −3.5% | Jun 30, 2026 |
| Vestal Point Capital, LP | 7.93% | 5.25M | $91.82M | −3.2% | Jun 30, 2026 |
| Deep Track Capital, Lp | 6.20% | 4.10M | $71.71M | +0.9% | Jun 30, 2026 |
| Blackrock Inc. | 5.82% | 3.85M | $67.30M | +35.3% | Jun 30, 2026 |
| Jupiter Topco LLC | 4.79% | 3.17M | $55.46M | +100.0% | Jun 30, 2026 |
| Red Tree Management, LLC | 4.78% | 3.16M | $55.33M | −0.2% | Jun 30, 2026 |
| TPG GP A, LLC | 4.55% | 3.01M | $52.65M | 0.0% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 3.35% | 2.22M | $38.77M | +24.9% | Jun 30, 2026 |
Top Funds
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock Fund, Inc. | 3.29% | 2.18M | $38.12M | −0.1% | Jun 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.53% | 1.68M | $29.32M | +22.3% | Jun 30, 2026 |
| T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 1.77% | 1.17M | $20.47M | −2.2% | Jun 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.75% | 1.16M | $20.25M | +7.5% | Aug 31, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.71% | 1.13M | $19.81M | +0.7% | Aug 31, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Core Equity Trust | 1.52% | 1.00M | $17.56M | −2.9% | Jun 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.36% | 902.00K | $15.78M | −4.5% | Aug 31, 2026 |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 0.94% | 623.69K | $10.91M | +23.5% | Jul 31, 2026 |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 0.93% | 612.10K | $10.71M | +112.7% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.91% | 604.73K | $10.58M | −14.2% | Jun 30, 2026 |
Institutions report quarterly, up to 45 days after the quarter ends, so these positions can be months old. Change compares the share count with the holder's previous filing. Insider transactions are on the overview page (INSD).